COVID-19: Risk Assessment and Treatment
COVID-19: Risk Assessment and Treatment
COVID-19: Risk Assessment and Treatment
DOT
The newest Coronavirus has been classified as a member of the species severe acute respiratory syndrome-related Coronavirus and has been designated as severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2. It is commonly referred to as "coronavirus disease 2019" and abbreviated "COVID-19." The World Health Organization declared COVID-19 a pandemic on March 11, 2020. All 50 states have reported cases of COVID-19 to the CDC. Best practices continue to evolve as additional information and guidance become available regarding this disease.
COURSE INFORMATION
Brittany Kleszynski, DVM 45 minValid for 12 monthsCreated 2020-04-06Updated 2020-10-28
Course Objectives
- Review the methods of transmission of COVID-19, its incubation period, possible associated risk factors, and the typical clinical presentation associated with COVID-19 infection.
- Recognize common myths associated with COVID-19 and recommended responses to use during patient engagement.
- Identify those persons at the highest risk of COVID-19 infection and those at high-risk for severe illness from COVID-19.
- Discuss possible therapeutic options for COVID-19 patients.
- Review evidence-based guidelines regarding protecting yourself, your patients, and your workforce from COVID-19.
Other DOT courses
